Investing.com - Trinity reported on Tuesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Trinity announced earnings per share of $-0.04 on revenue of $16.02M. Analysts polled by Investing.com anticipated EPS of $-0.02 on revenue of $13M.
Trinity shares are up 88.77% from the beginning of the year, still down 40.37% from its 52 week high of $3.27 set on July 21. They are outperforming the Nasdaq which is up 27.45% from the start of the year.
Trinity shares gained 16.07% in intra-day trade following the report.
Trinity follows other major Healthcare sector earnings this month
Trinity's report follows an earnings beat by Merck&Co on July 31, who reported EPS of $1.37 on revenue of $10.87B, compared to forecasts EPS of $1.06 on revenue of $10.4B.
Pfizer had beat expectations on July 28 with second quarter EPS of $0.78 on revenue of $11.8B, compared to forecast for EPS of $0.68 on revenue of $11.54B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar